Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
NanoBio Corp received early financing of $30.0M on 2006-10-21.
| Series | Round size | Date |
|---|---|---|
| Series A | $30M | 10/2006 |
| Series B | $12M | 02/2009 |
| Series B | $10M | 07/2009 |
| Grant | $6M | 11/2010 |
| Series C | $11M | 11/2012 |
| Grant | $5.5M | 10/2013 |
| Convertible Note | $1.8M | 02/2016 |
| Series A | $10M | 05/2018 |
| Investors | Security type |
|---|---|
| Perseus | Series A |
| Perseus | Series B |
| Perseus | Series B |
| Venture Investors LLC | Series B |
| Bill & Melinda Gates Foundation | Grant |
| Perseus | Series C |
| Venture Investors LLC | Series C |
| National Institute of Allergy and Infectious Diseases (NIAID) | Grant |
| Line Moon Ventures | Series A |
| University of Michigan MINTS fund | Series A |
| North Coast Technology Investors | Series A |
NanoBio Corp's top competitor, Dynavax Technologies, earned an annual revenue of $277.2M.
NanoBio Corp's smallest competitor is GeoVax with revenue of $81.5K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| NovaBay Pharmaceuticals | - | $14.4M | 25 | - |
| Dynavax Technologies | - | $277.2M | 311 | - |
| Vaxart | - | $28.7M | 110 | - |
| Anacor Pharmaceutical | - | $82.4M | 100 | - |
| GeoVax | - | $81,526 | 5 | - |
| Alios BioPharma | - | $15.7M | 75 | - |
| NanoViricides | - | $4.6M | 17 | - |
| Icosavax | - | $582,000 | 34 | - |
| Profectus BioSciences Inc. | - | $1.1M | 16 | - |
Zippia gives an in-depth look into the details of NanoBio Corp, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NanoBio Corp. The employee data is based on information from people who have self-reported their past or current employments at NanoBio Corp. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NanoBio Corp. The data presented on this page does not represent the view of NanoBio Corp and its employees or that of Zippia.
NanoBio Corp may also be known as or be related to NanoBio Corp.